BILCAP ASCO 2017 Capcetabine Drug improves survival of patients with r
- This topic has 1 reply, 1 voice, and was last updated 7 years, 2 months ago by
.
Viewing 2 posts - 1 through 2 (of 2 total)
-
Posts
-
Adjuvant capecitabine for biliary tract cancer: The BILCAP randomized study.
http://abstracts.asco.org/199/AbstView_199_186869.html
Drug improves survival of patients with rare cancer by almost a quarter.
Please Read the Cancer Research Press Release here –
The ASCO 2017 Annual Meeting abstracts are out now and I will post the links to all of them here on the site this evening.
Gavin
Viewing 2 posts - 1 through 2 (of 2 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.